Clinical Trial Update: Phase II of High-dose Therapy in Elderly Patients With Relapsed Aggressive NHL or Resistant to First Line Therapy [Phase 2]

View source ↗

Summary

A Phase II clinical trial update evaluating high-dose therapy in elderly patients with relapsed aggressive non-Hodgkin lymphoma or resistance to first-line ther…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Snippet

Sponsor: Fondazione Italiana Linfomi - ETS | Conditions: Non Hodgkin Lymphoma | Phase 2 | Status: UNKNOWN